March 31, 2026 · Form 4 insider transaction
Lind Kevin Robert bought 1,370 shares of Avalo Therapeutics, Inc. at $12.13 per share, a transaction worth $16.6K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
The options were granted on March 31, 2026, and are 100% vested.